Identification and Antifungal Susceptibility Profiles of Cyberlindnera fabianii in Korea

References

• Svobodova L, Bednarova D, Ruzicka F, et al. High frequency of Candida fabianii among clinical isolates biochemically identified as Candida pelliculosa and Candida utilis. Mycoses. 2016;59:241–246.
   Web of Science ®Google Scholar
• Grenouillet F, Millon L, Chamouine A, et al. Pichia fabianii fungemia in a neonate. Pediatr Infect Dis J. 2010;29:191.
   PubMed Web of Science ®Google Scholar
• Wu Y, Wang J, Li W, et al. Pichia fabianii blood infection in a premature infant in China: case report. BMC Res Notes. 2013;6:77.
   Google Scholar
• Yun JW, Park KS, Ki CS, et al. Catheter-related bloodstream infection by Lindnera fabianii in a neutropenic patient. J Med Microbiol. 2013;62:922–925.
   Web of Science ®Google Scholar
• Mlinarić-Missoni E, Hatvani L, Kocsubé S, et al. Cyberlindnera fabianii in the neonatal and paediatric intensive care unit: case reports. JMM Case Rep. 2015;2:1–6. https://doi.org/10.1099/jmmcr.0.000032.
   Google Scholar
• Lee JI, Yu S, Park JS, et al. Successful treatment of fungemia caused by Cyberlindnera fabianii with Anidulafungin: a case report. Ann Clin Microbiol. 2015;18:94–97.
   Google Scholar
• Kim YJ, Yang JJ, Lee HJ. Possibility of frequent detection of invasive Cyberlindnera fabianii infection using molecular method. Ann Clin Microbiol. 2015;18:133–134.
   Google Scholar
• White TJ, Bruns T, Lee S, et al. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR protocols: a guide to methods and applications. San Diego, CA, USA: Academic Press; 1990. p. 315–322.
   Google Scholar
• O'Donnell K. Fusarium and its near relatives In: Reynolds DR, Taylor JW, editors. The fungal holomorph: mitotic, meiotic and pleomorphic speciation in fungal systematics. Wallingford, United Kingdom: CAB International; 1993. p. 529–580.
   Google Scholar
• Tamura K, Stecher G, Peterson D, et al. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol. 2013;30:2725–2729.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute (CLSI). M27-S4 Reference method for broth dilution antifungal susceptibility testing of yeasts: fourth informational supplement M27-S4. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.
   Google Scholar
• Minter DW. Cyberlindnera, a replacement name for Lindnera kurtzman et al., nom. illegit. Mycotaxon. 2009;110:473–476.
   Web of Science ®Google Scholar
• Hamal P, Ostransky J, Dendis M, et al. A case of endocarditis caused by the yeast Pichia fabianii with biofilm production and developed in vitro resistance to azoles in the course of antifungal treatment. Med Mycol. 2008;46:601–605.
   PubMed Web of Science ®Google Scholar
• Baghdadi J, Hemarajata P, Humphries R, et al. First report of ventriculoperitoneal shunt infection due to Cyberlindnera fabianii. Case Rep Infect Dis. 2015;630816:1–6.
   Google Scholar
• Jindal N, Arora S, Dhuria N, et al. Cyberlindnera (Pichia) fabianii infection in a neutropenic child: importance of molecular identification. JMM Case Rep. 2015;2:1–3. http://dx.doi.org/10.1099/jmmcr.0.000033.
   Google Scholar
• Hof H, Amann V, Tauber C, et al. Peritonitis in a neonate due to Cyberlindnera fabianii, an ascomycetic yeast. Infection. 2017;45:921–924.
   Web of Science ®Google Scholar
• Bhally HS, Jain S, Shields C, et al. Infection in a neonate caused by Pichia fabianii: importance of molecular identification. Med Mycol. 2006;44:185–187.
   PubMed Web of Science ®Google Scholar
• Gabriel F, Noel T, Accoceberry I. Lindnera (Pichia) fabianii blood infection after mesenteric ischemia. Med Mycol. 2012;50:310–314.
   PubMed Web of Science ®Google Scholar
• Valenza G, Valenza R, Brederlau J, et al. Identification of Candida fabianii as a causal of lethal septicaemia. Mycoses. 2006;49:331–334.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Tsang CC, Xiao M, et al. Yeast identification by sequencing, biochemical kits, MALDI-TOF MS and rep-PCR DNA fingerprinting. Med Mycol. 2018;56:816–827.
   Web of Science ®Google Scholar
• Haas M, Grenouillet F, Loubersac S, et al. Identification of cryptic Candida species by MALDI-TOF mass spectrometry, not all MALDI-TOF systems are the same: focus on the C. parapsilosis species complex. Diagn Microbial Infect Dis. 2016;84:385–386.
   Google Scholar
• Ghosh AK, Paul S, Sood P, et al. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for the rapid identification of yeasts causing bloodstream infections. Clin Microbiol Infect. 2015;21:372–378.
   PubMed Web of Science ®Google Scholar
• Richard MJ, Edwards JR, Culver DH, et al. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med. 1999;27:887–892.
   Web of Science ®Google Scholar
• Nicolle LE. Catheter associated urinary tract infections. Antimicrob Resist Infect Control. 2014;3:23.
   PubMed Web of Science ®Google Scholar
• Kaur R, Dhakad MS, Goyal R, et al. Emergence of non-albicans Candida species and antifungal resistance in intensive care unit patients. Asian Pac J Trop Biomed. 2016;6:455–460.
   Web of Science ®Google Scholar
• Bukhary ZA. Candiduria: a review of clinical significance and management. Saudi J Kidney Dis Transpl. 2008;19:350–360.
   Google Scholar
• Kauffman CA. Candiduria. Clin Infect Dis. 2005;41:S371–S376.
   PubMed Web of Science ®Google Scholar